---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-120902"
form_type: "8-K"
ticker: "HRTX"
cik: "0000818033"
company_name: "HERON THERAPEUTICS, INC. /DE/"
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:36:17.123744+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Heron Therapeutics appoints Michael Kaseta to Board of Directors

## Summary
- Michael Kaseta, CFO/COO of Liquidia, appointed to Heron's Board effective Nov. 4, 2024.
- Kaseta brings biopharma finance and commercial expertise; served as CFO at Aerami and Aralez.
- Previously CFO of Sanofi North America, managing a $10B business across 100+ products.
- Will receive standard non-employee director compensation and enter indemnification agreement.

## SEC filing metadata
- accession: 0000950170-24-120902
- form_type: 8-K
- ticker: HRTX
- cik: 0000818033
- company_name: HERON THERAPEUTICS, INC. /DE/
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/0000950170-24-120902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/hrtx-20241104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-120902
- JSON: https://secwatch.observer/filing/0000950170-24-120902.json
- Plain text: https://secwatch.observer/filing/0000950170-24-120902.txt

## Key facts
- Executive change
  Michael Kaseta was appointed as Director at HERON THERAPEUTICS, INC. /DE/.
  - Action: appointed
  - Role: Director
  source text: On November 4, 2024, the Board of Directors (the "Board") of Heron Therapeutics, Inc. (the "Company") appointed Michael Kaseta to the Board to serve for a term expiring at the Company’s 2025 annual meeting of stockholders and until his successor is duly elected and qualified or until his earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/818033/000095017024120902/0000950170-24-120902-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.